MaRS Monthly Roundup – September 2023

The large-scale facility will support the development and commercialization of the Vertex type 1 diabetes (T1D) cell therapy portfolioAt the facility’s groundbreaking event on August 30th, Lonza and Vertex were joined by New Hampshire government officials to commemorate the milestonePortsmouth, NH, — Lonza and Vertex Pharmaceuticals Incorporated (Vertex) celebrated the groundbreaking of a dedicate